Global and United States G-CSF and G-CSF Biosimilars Market Report & Forecast 2023-2028

Report ID: 1816373 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 G-CSF and G-CSF Biosimilars Product Introduction
    1.2 Global G-CSF and G-CSF Biosimilars Outlook 2017 VS 2022 VS 2028
        1.2.1 Global G-CSF and G-CSF Biosimilars Sales in US$ Million for the Year 2017-2028
        1.2.2 Global G-CSF and G-CSF Biosimilars Sales in Volume for the Year 2017-2028
    1.3 United States G-CSF and G-CSF Biosimilars Outlook 2017 VS 2022 VS 2028
        1.3.1 United States G-CSF and G-CSF Biosimilars Sales in US$ Million for the Year 2017-2028
        1.3.2 United States G-CSF and G-CSF Biosimilars Sales in Volume for the Year 2017-2028
    1.4 G-CSF and G-CSF Biosimilars Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States G-CSF and G-CSF Biosimilars in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of G-CSF and G-CSF Biosimilars Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 G-CSF and G-CSF Biosimilars Market Dynamics
        1.5.1 G-CSF and G-CSF Biosimilars Industry Trends
        1.5.2 G-CSF and G-CSF Biosimilars Market Drivers
        1.5.3 G-CSF and G-CSF Biosimilars Market Challenges
        1.5.4 G-CSF and G-CSF Biosimilars Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 G-CSF and G-CSF Biosimilars Market Segment by Type
        2.1.1 Blood Disorders
        2.1.2 Oncology Diseases
        2.1.3 Chronic And Autoimmune Diseases
        2.1.4 Growth Hormone Deficiencies
    2.2 Global G-CSF and G-CSF Biosimilars Market Size by Type
        2.2.1 Global G-CSF and G-CSF Biosimilars Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global G-CSF and G-CSF Biosimilars Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States G-CSF and G-CSF Biosimilars Market Size by Type
        2.3.1 United States G-CSF and G-CSF Biosimilars Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States G-CSF and G-CSF Biosimilars Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 G-CSF and G-CSF Biosimilars Market Segment by Application
        3.1.1 Human Growth Hormone
        3.1.2 Erythropoietin
        3.1.3 Monoclonal Antibodies
        3.1.4 Insulin
        3.1.5 Interferon
    3.2 Global G-CSF and G-CSF Biosimilars Market Size by Application
        3.2.1 Global G-CSF and G-CSF Biosimilars Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global G-CSF and G-CSF Biosimilars Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States G-CSF and G-CSF Biosimilars Market Size by Application
        3.3.1 United States G-CSF and G-CSF Biosimilars Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States G-CSF and G-CSF Biosimilars Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global G-CSF and G-CSF Biosimilars Competitor Landscape by Company
    4.1 Global G-CSF and G-CSF Biosimilars Market Size by Company
        4.1.1 Top Global G-CSF and G-CSF Biosimilars Manufacturers Ranked by Revenue (2021)
        4.1.2 Global G-CSF and G-CSF Biosimilars Revenue by Manufacturer (2017-2022)
        4.1.3 Global G-CSF and G-CSF Biosimilars Sales by Manufacturer (2017-2022)
        4.1.4 Global G-CSF and G-CSF Biosimilars Price by Manufacturer (2017-2022)
    4.2 Global G-CSF and G-CSF Biosimilars Concentration Ratio (CR)
        4.2.1 G-CSF and G-CSF Biosimilars Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of G-CSF and G-CSF Biosimilars in 2021
        4.2.3 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global G-CSF and G-CSF Biosimilars Manufacturing Base Distribution, Product Type
        4.3.1 Global G-CSF and G-CSF Biosimilars Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers G-CSF and G-CSF Biosimilars Product Type
        4.3.3 Date of International Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States G-CSF and G-CSF Biosimilars Market Size by Company
        4.5.1 Top G-CSF and G-CSF Biosimilars Players in United States, Ranked by Revenue (2021)
        4.5.2 United States G-CSF and G-CSF Biosimilars Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States G-CSF and G-CSF Biosimilars Sales by Players (2020, 2021 & 2022)
5 Global G-CSF and G-CSF Biosimilars Market Size by Region
    5.1 Global G-CSF and G-CSF Biosimilars Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global G-CSF and G-CSF Biosimilars Market Size in Volume by Region (2017-2028)
        5.2.1 Global G-CSF and G-CSF Biosimilars Sales in Volume by Region: 2017-2022
        5.2.2 Global G-CSF and G-CSF Biosimilars Sales in Volume Forecast by Region (2023-2028)
    5.3 Global G-CSF and G-CSF Biosimilars Market Size in Value by Region (2017-2028)
        5.3.1 Global G-CSF and G-CSF Biosimilars Sales in Value by Region: 2017-2022
        5.3.2 Global G-CSF and G-CSF Biosimilars Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America G-CSF and G-CSF Biosimilars Market Size YoY Growth 2017-2028
        6.1.2 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific G-CSF and G-CSF Biosimilars Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe G-CSF and G-CSF Biosimilars Market Size YoY Growth 2017-2028
        6.3.2 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America G-CSF and G-CSF Biosimilars Market Size YoY Growth 2017-2028
        6.4.2 Latin America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporation Information
        7.1.2 Pfizer Description and Business Overview
        7.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
        7.1.5 Pfizer Recent Development
    7.2 Novartis
        7.2.1 Novartis Corporation Information
        7.2.2 Novartis Description and Business Overview
        7.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Novartis G-CSF and G-CSF Biosimilars Products Offered
        7.2.5 Novartis Recent Development
    7.3 Roche
        7.3.1 Roche Corporation Information
        7.3.2 Roche Description and Business Overview
        7.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Roche G-CSF and G-CSF Biosimilars Products Offered
        7.3.5 Roche Recent Development
    7.4 Merck & Co.
        7.4.1 Merck & Co. Corporation Information
        7.4.2 Merck & Co. Description and Business Overview
        7.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Products Offered
        7.4.5 Merck & Co. Recent Development
    7.5 Sanofi
        7.5.1 Sanofi Corporation Information
        7.5.2 Sanofi Description and Business Overview
        7.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Sanofi G-CSF and G-CSF Biosimilars Products Offered
        7.5.5 Sanofi Recent Development
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Corporation Information
        7.6.2 Johnson & Johnson Description and Business Overview
        7.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Products Offered
        7.6.5 Johnson & Johnson Recent Development
    7.7 Gilead Science
        7.7.1 Gilead Science Corporation Information
        7.7.2 Gilead Science Description and Business Overview
        7.7.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Gilead Science G-CSF and G-CSF Biosimilars Products Offered
        7.7.5 Gilead Science Recent Development
    7.8 GlaxoSmithKline
        7.8.1 GlaxoSmithKline Corporation Information
        7.8.2 GlaxoSmithKline Description and Business Overview
        7.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Products Offered
        7.8.5 GlaxoSmithKline Recent Development
    7.9 AbbVie
        7.9.1 AbbVie Corporation Information
        7.9.2 AbbVie Description and Business Overview
        7.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 AbbVie G-CSF and G-CSF Biosimilars Products Offered
        7.9.5 AbbVie Recent Development
    7.10 Amgen
        7.10.1 Amgen Corporation Information
        7.10.2 Amgen Description and Business Overview
        7.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Amgen G-CSF and G-CSF Biosimilars Products Offered
        7.10.5 Amgen Recent Development
    7.11 AstraZeneca
        7.11.1 AstraZeneca Corporation Information
        7.11.2 AstraZeneca Description and Business Overview
        7.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Products Offered
        7.11.5 AstraZeneca Recent Development
    7.12 Bayer
        7.12.1 Bayer Corporation Information
        7.12.2 Bayer Description and Business Overview
        7.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Bayer Products Offered
        7.12.5 Bayer Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 G-CSF and G-CSF Biosimilars Industry Chain Analysis
    8.2 G-CSF and G-CSF Biosimilars Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 G-CSF and G-CSF Biosimilars Distributors
    8.3 G-CSF and G-CSF Biosimilars Production Mode & Process
    8.4 G-CSF and G-CSF Biosimilars Sales and Marketing
        8.4.1 G-CSF and G-CSF Biosimilars Sales Channels
        8.4.2 G-CSF and G-CSF Biosimilars Distributors
    8.5 G-CSF and G-CSF Biosimilars Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. G-CSF and G-CSF Biosimilars CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. G-CSF and G-CSF Biosimilars Market Trends
    Table 3. G-CSF and G-CSF Biosimilars Market Drivers
    Table 4. G-CSF and G-CSF Biosimilars Market Challenges
    Table 5. G-CSF and G-CSF Biosimilars Market Restraints
    Table 6. Global G-CSF and G-CSF Biosimilars Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States G-CSF and G-CSF Biosimilars Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global G-CSF and G-CSF Biosimilars Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States G-CSF and G-CSF Biosimilars Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top G-CSF and G-CSF Biosimilars Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global G-CSF and G-CSF Biosimilars Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global G-CSF and G-CSF Biosimilars Revenue Share by Manufacturer, 2017-2022
    Table 13. Global G-CSF and G-CSF Biosimilars Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global G-CSF and G-CSF Biosimilars Sales Share by Manufacturer, 2017-2022
    Table 15. Global G-CSF and G-CSF Biosimilars Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global G-CSF and G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global G-CSF and G-CSF Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2021)
    Table 18. Top Players of G-CSF and G-CSF Biosimilars in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers G-CSF and G-CSF Biosimilars Product Type
    Table 20. Date of International Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top G-CSF and G-CSF Biosimilars Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States G-CSF and G-CSF Biosimilars Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States G-CSF and G-CSF Biosimilars Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States G-CSF and G-CSF Biosimilars Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States G-CSF and G-CSF Biosimilars Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global G-CSF and G-CSF Biosimilars Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global G-CSF and G-CSF Biosimilars Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global G-CSF and G-CSF Biosimilars Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global G-CSF and G-CSF Biosimilars Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global G-CSF and G-CSF Biosimilars Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America G-CSF and G-CSF Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America G-CSF and G-CSF Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific G-CSF and G-CSF Biosimilars Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific G-CSF and G-CSF Biosimilars Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe G-CSF and G-CSF Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe G-CSF and G-CSF Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America G-CSF and G-CSF Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa G-CSF and G-CSF Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa G-CSF and G-CSF Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa G-CSF and G-CSF Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer G-CSF and G-CSF Biosimilars Product
    Table 46. Pfizer Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Novartis Product
    Table 51. Novartis Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. Merck & Co. Corporation Information
    Table 58. Merck & Co. Description and Business Overview
    Table 59. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Merck & Co. Product
    Table 61. Merck & Co. Recent Development
    Table 62. Sanofi Corporation Information
    Table 63. Sanofi Description and Business Overview
    Table 64. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Sanofi Product
    Table 66. Sanofi Recent Development
    Table 67. Johnson & Johnson Corporation Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Johnson & Johnson Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. Gilead Science Corporation Information
    Table 73. Gilead Science Description and Business Overview
    Table 74. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Gilead Science Product
    Table 76. Gilead Science Recent Development
    Table 77. GlaxoSmithKline Corporation Information
    Table 78. GlaxoSmithKline Description and Business Overview
    Table 79. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. GlaxoSmithKline Product
    Table 81. GlaxoSmithKline Recent Development
    Table 82. AbbVie Corporation Information
    Table 83. AbbVie Description and Business Overview
    Table 84. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. AbbVie Product
    Table 86. AbbVie Recent Development
    Table 87. Amgen Corporation Information
    Table 88. Amgen Description and Business Overview
    Table 89. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Amgen Product
    Table 91. Amgen Recent Development
    Table 92. AstraZeneca Corporation Information
    Table 93. AstraZeneca Description and Business Overview
    Table 94. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. AstraZeneca Product
    Table 96. AstraZeneca Recent Development
    Table 97. Bayer Corporation Information
    Table 98. Bayer Description and Business Overview
    Table 99. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Bayer Product
    Table 101. Bayer Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. G-CSF and G-CSF Biosimilars Customers List
    Table 105. G-CSF and G-CSF Biosimilars Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. G-CSF and G-CSF Biosimilars Product Picture
    Figure 2. Global G-CSF and G-CSF Biosimilars Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global G-CSF and G-CSF Biosimilars Market Size 2017-2028 (US$ Million)
    Figure 4. Global G-CSF and G-CSF Biosimilars Sales 2017-2028 (K Units)
    Figure 5. United States G-CSF and G-CSF Biosimilars Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States G-CSF and G-CSF Biosimilars Market Size 2017-2028 (US$ Million)
    Figure 7. United States G-CSF and G-CSF Biosimilars Sales 2017-2028 (K Units)
    Figure 8. United States G-CSF and G-CSF Biosimilars Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States G-CSF and G-CSF Biosimilars Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. G-CSF and G-CSF Biosimilars Report Years Considered
    Figure 11. Product Picture of Blood Disorders
    Figure 12. Product Picture of Oncology Diseases
    Figure 13. Product Picture of Chronic And Autoimmune Diseases
    Figure 14. Product Picture of Growth Hormone Deficiencies
    Figure 15. Global G-CSF and G-CSF Biosimilars Market Share by Type in 2022 & 2028
    Figure 16. Global G-CSF and G-CSF Biosimilars Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global G-CSF and G-CSF Biosimilars Sales by Type (2017-2028) & (K Units)
    Figure 19. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global G-CSF and G-CSF Biosimilars Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States G-CSF and G-CSF Biosimilars Market Share by Type in 2022 & 2028
    Figure 22. United States G-CSF and G-CSF Biosimilars Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States G-CSF and G-CSF Biosimilars Sales by Type (2017-2028) & (K Units)
    Figure 25. United States G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States G-CSF and G-CSF Biosimilars Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Human Growth Hormone
    Figure 28. Product Picture of Erythropoietin
    Figure 29. Product Picture of Monoclonal Antibodies
    Figure 30. Product Picture of Insulin
    Figure 31. Product Picture of Interferon
    Figure 32. Global G-CSF and G-CSF Biosimilars Market Share by Application in 2022 & 2028
    Figure 33. Global G-CSF and G-CSF Biosimilars Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global G-CSF and G-CSF Biosimilars Sales by Application (2017-2028) & (K Units)
    Figure 36. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global G-CSF and G-CSF Biosimilars Price by Application (2017-2028) & (USD/Unit)
    Figure 38. United States G-CSF and G-CSF Biosimilars Market Share by Application in 2022 & 2028
    Figure 39. United States G-CSF and G-CSF Biosimilars Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States G-CSF and G-CSF Biosimilars Sales by Application (2017-2028) & (K Units)
    Figure 42. United States G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States G-CSF and G-CSF Biosimilars Price by Application (2017-2028) & (USD/Unit)
    Figure 44. North America G-CSF and G-CSF Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. North America G-CSF and G-CSF Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. U.S. G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe G-CSF and G-CSF Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 49. Europe G-CSF and G-CSF Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific G-CSF and G-CSF Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 56. Asia-Pacific G-CSF and G-CSF Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Taiwan G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Latin America G-CSF and G-CSF Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Latin America G-CSF and G-CSF Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Mexico G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Brazil G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Argentina G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa G-CSF and G-CSF Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 73. Middle East & Africa G-CSF and G-CSF Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. U.A.E G-CSF and G-CSF Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. G-CSF and G-CSF Biosimilars Value Chain
    Figure 78. G-CSF and G-CSF Biosimilars Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Frequently Asked Questions
G-CSF and G-CSF Biosimilars report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
G-CSF and G-CSF Biosimilars report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
G-CSF and G-CSF Biosimilars report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Steel Silo

Steel Silo market is segmented by region (country), players, by Type and by Application. Players, ... Read More